Thermo Fisher Scientific Inc. (TMO)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS8835561023
695.42 USD
-0.57% today Updated 13 Nov 2026 16:47
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Thermo Fisher Scientific Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:47. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
28 Jan 2027
in 76 days · 08:00 · estimate 7.13
Last results
6.68 vs 6.40 estimated
21 Oct 2026 · Beat +4.3%
Beat the estimate
9 of 12
0 missed · 3 in line · 6 beats in a row
Average surprise
+3.4%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 08:00 | 7.13 | — | — | Upcoming |
| 21 Oct 2026 06:00 | 6.40 | 6.68 | +4.3% | Beat |
| 23 Jul 2026 06:00 | 5.71 | 6.03 | +5.6% | Beat |
| 23 Apr 2026 06:00 | 5.24 | 5.44 | +3.8% | Beat |
| 29 Jan 2026 06:00 | 6.45 | 6.57 | +1.9% | Beat |
| 22 Oct 2025 06:00 | 5.50 | 5.79 | +5.3% | Beat |
| 23 Jul 2025 06:00 | 5.23 | 5.36 | +2.6% | Beat |
| 23 Apr 2025 06:00 | 5.10 | 5.15 | +0.9% | In line |
| 30 Jan 2025 06:00 | 5.94 | 6.10 | +2.7% | Beat |
| 23 Oct 2024 06:00 | 5.25 | 5.28 | +0.5% | In line |
| 24 Jul 2024 06:00 | 5.13 | 5.37 | +4.7% | Beat |
| 24 Apr 2024 06:00 | 4.71 | 5.11 | +8.5% | Beat |
| 31 Jan 2024 06:00 | 5.65 | 5.67 | +0.4% | In line |
| 25 Oct 2023 06:00 | 5.61 | 5.69 | +1.4% | Beat |
| 26 Jul 2023 06:00 | 5.43 | 5.15 | -5.2% | Miss |
| 26 Apr 2023 06:00 | 5.03 | 5.03 | -0.1% | In line |
| 01 Feb 2023 06:00 | 5.20 | 5.40 | +3.8% | Beat |
| 26 Oct 2022 06:00 | 4.82 | 5.08 | +5.5% | Beat |
| 28 Jul 2022 06:00 | 4.98 | 5.51 | +10.6% | Beat |
| 28 Apr 2022 06:00 | 6.21 | 7.25 | +16.8% | Beat |
| 02 Feb 2022 06:00 | 5.27 | 6.54 | +24.0% | Beat |
| 27 Oct 2021 06:00 | 4.70 | 5.76 | +22.7% | Beat |
| 28 Jul 2021 06:00 | 5.47 | 5.60 | +2.3% | Beat |
| 29 Apr 2021 06:00 | 6.68 | 7.21 | +7.9% | Beat |
| 01 Feb 2021 06:00 | 6.57 | 7.09 | +7.9% | Beat |
| 21 Oct 2020 06:00 | 4.30 | 5.63 | +30.8% | Beat |
| 22 Jul 2020 06:00 | 2.89 | 3.89 | +34.6% | Beat |
| 22 Apr 2020 06:00 | 2.82 | 2.94 | +4.4% | Beat |
| 30 Jan 2020 06:00 | 3.54 | 3.55 | +0.4% | In line |
| 23 Oct 2019 06:00 | 2.89 | 2.94 | +1.8% | Beat |
| 24 Jul 2019 06:00 | 3.00 | 3.04 | +1.4% | Beat |
| 24 Apr 2019 06:00 | 2.74 | 2.81 | +2.7% | Beat |
| 30 Jan 2019 06:00 | 3.18 | 3.25 | +2.4% | Beat |
| 24 Oct 2018 06:00 | 2.56 | 2.62 | +2.2% | Beat |
| 25 Jul 2018 06:00 | 2.63 | 2.75 | +4.7% | Beat |
| 25 Apr 2018 06:00 | 2.41 | 2.50 | +3.9% | Beat |
| 31 Jan 2018 06:00 | 2.67 | 2.79 | +4.5% | Beat |
| 25 Oct 2017 06:00 | 2.25 | 2.31 | +2.8% | Beat |
| 26 Jul 2017 06:00 | 2.27 | 2.30 | +1.2% | Beat |
| 26 Apr 2017 06:00 | 2.02 | 2.08 | +2.8% | Beat |
| 31 Jan 2017 06:00 | 2.38 | 2.41 | +1.3% | Beat |
| 27 Oct 2016 06:00 | 1.97 | 2.03 | +2.9% | Beat |
| 28 Jul 2016 06:00 | 2.01 | 2.03 | +0.8% | In line |
| 28 Apr 2016 06:00 | 1.74 | 1.80 | +3.2% | Beat |
| 28 Jan 2016 06:00 | 2.11 | 2.12 | +0.6% | In line |
| 21 Oct 2015 06:00 | 1.79 | 1.80 | +0.6% | In line |
| 22 Jul 2015 06:00 | 1.78 | 1.84 | +3.3% | Beat |
| 22 Apr 2015 06:00 | 1.61 | 1.63 | +1.3% | Beat |
| 29 Jan 2015 06:00 | 1.94 | 1.99 | +2.5% | Beat |
| 22 Oct 2014 06:00 | 1.69 | 1.71 | +1.2% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 44.6B | +3.9% | 6.7B | 15.0% | 17.74 | +7.3% | 6.3B |
| 2024 | 42.9B | +0.1% | 6.3B | 14.8% | 16.53 | +7.0% | 7.3B |
| 2023 | 42.9B | -4.6% | 6B | 14.0% | 15.45 | -12.4% | 6.9B |
| 2022 | 44.9B | — | 7B | 15.5% | 17.63 | — | 6.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 699.86 | 727.56 | 661.60 | 695.42 | -0.23% | 18,961,592 | |
| Oct 2026 | 672.39 | 711.85 | 635.32 | 697.00 | +3.25% | 51,755,600 | |
| Sep 2026 | 619.00 | 683.63 | 594.82 | 675.05 | +9.39% | 47,007,500 | 0.4700 |
| Aug 2026 | 576.00 | 647.00 | 562.50 | 617.10 | +7.45% | 35,005,900 | |
| Jul 2026 | 504.78 | 588.56 | 495.04 | 574.30 | +14.55% | 49,292,000 | |
| Jun 2026 | 489.83 | 515.96 | 457.64 | 501.36 | +1.80% | 48,137,100 | 0.4700 |
| May 2026 | 480.00 | 499.00 | 435.27 | 492.51 | +2.83% | 52,871,000 | |
| Apr 2026 | 496.30 | 538.41 | 455.60 | 478.96 | -2.56% | 41,903,800 | |
| Mar 2026 | 512.01 | 520.58 | 458.34 | 491.53 | -5.68% | 47,394,200 | 0.4700 |
| Feb 2026 | 575.90 | 588.85 | 493.64 | 521.11 | -9.94% | 45,953,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- What Happened To People Who Bought Thermo Fisher Stock At A High? (opens in a new tab) Trefis · 12 Nov 2026 18:55
- Is Thermo Fisher Scientific (TMO) Reasonable After Its $5 Billion Buyback? (opens in a new tab) Simply Wall St. · 12 Nov 2026 16:12
- Thermo Fisher Scientific (TMO), Why Is It Back In The Spotlight? (opens in a new tab) Simply Wall St. · 12 Nov 2026 15:11
- Cell Culture Protein Surface Coating - Global Strategic Business Report 2026: Capitalize on the $2.1B Market by 2032 as Corning, Merck, Sartorius and Thermo Fisher Accelerate Competition (opens in a new tab) 12 Nov 2026 15:01
- Cell Lysis / Cell Fractionation - Global Strategic Business Report 2026: Capture the $4.5 Billion Market by 2032 | Features Competitive Intelligence on Thermo Fisher, Beckman Coulter, Bio-Rad, Qiagen and Merck (opens in a new tab) 12 Nov 2026 15:00
- Single-Use Bioprocessing - Global Strategic Business Report 2026: Capitalize on 13.4% CAGR to $47.7B by 2032, Featuring Profiles of Danaher, Thermo Fisher Scientific, 3M, and Eppendorf (opens in a new tab) 12 Nov 2026 14:54
- Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher and More (opens in a new tab) 11 Nov 2026 14:44
- Mass Spectrometry - Global Strategic Business Report 2026-2032 Featuring Thermo Fisher, Agilent, Bruker, Shimadzu, Waters and More (opens in a new tab) 11 Nov 2026 14:42
- Transfection Technologies - Global Strategic Business Report 2026: Capitalize on a $2.5 Billion Market by 2032 as Thermo Fisher, Lonza, Bio-Rad, Qiagen and MilliporeSigma Accelerate (opens in a new tab) 11 Nov 2026 14:21
- Whole Exome Sequencing - Global Strategic Business Report 2026: Capitalize on 19.5% CAGR to $2.3 Billion by 2032 as Illumina, Thermo Fisher Scientific, BGI Genomics, and QIAGEN Accelerate (opens in a new tab) 11 Nov 2026 14:20
- Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032 (opens in a new tab) 11 Nov 2026 14:18
- Human Identification - Global Strategic Business Report 2026: Capitalize on 10.1% CAGR to $1.9 Billion by 2032 | Thermo Fisher, Illumina, Qiagen and Bio-Rad Vie for Shares (opens in a new tab) 11 Nov 2026 14:15
- Genomics - Global Strategic Business Report 2026: Capitalize on the $117.3 Billion Market by 2032, Featuring Strategic Intelligence on Illumina, Thermo Fisher Scientific, Danaher, and Oxford Nanopore (opens in a new tab) 11 Nov 2026 14:14
- Epigenetics - Global Strategic Business Report: Capitalize on an 18.2% CAGR to Secure the $5.5 Billion 2030 Market as Illumina, Thermo Fisher Scientific, Qiagen, and Bio-Rad Disrupt Precision Medicine (opens in a new tab) 11 Nov 2026 14:12
- Thermo Fisher Scientific (TMO) Is A Key Supplier In Cell Sheet Gene Therapy (opens in a new tab) Simply Wall St. · 11 Nov 2026 02:16
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 699.44 USD
- Market cap
- 257.7B
- Dividend yield
- 0.27%
- 5-year average yield
- 0.25%
- Payout ratio
- 10%
- Last dividend
- 0.4700 USD · 15 Dec 2026
- Next ex-dividend date
- 15 Dec 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 15 Sep 2026 | 0.4700 USD |
| 15 Jun 2026 | 0.4700 USD |
| 13 Mar 2026 | 0.4700 USD |
| 15 Dec 2025 | 0.4300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow TMO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.